WA
EW icon

WPG Advisers’s Edwards Lifesciences EW Stock Holding History

WPG Advisers’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35K Hold
37
– – ﹤0.01% 1072
2026
Q1 		$2.96K Sell
37
-4
-10% -$330 ﹤0.01% 1001
2025
Q4 		$3.5K Hold
41
– – ﹤0.01% 996
2025
Q3 		$3.19K Hold
41
– – ﹤0.01% 1023
2025
Q2 		$3.21K Buy
41
+4
+11% +$298 ﹤0.01% 1004
2025
Q1 		$2.68K Buy
37
+19
+106% +$1.36K ﹤0.01% 1053
2024
Q4 		$1.33K Buy
+18
New +$1.26K ﹤0.01% 1183

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

WPG Advisers's EW Position: Q2 2026 in Review

WPG Advisers held its Edwards Lifesciences (EW) position steady in Q2 2026 at 37 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

WPG Advisers first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.5K in Q4 2025. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • WPG Advisers held 37 shares of Edwards Lifesciences worth $3.35K as of Q2 2026.
  • WPG Advisers left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1072 holding.
  • WPG Advisers first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Edwards Lifesciences position peaked at $3.5K in Q4 2025.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.